Galapagos NV Stock Statistics
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
| Dates | Signal | Change |
|---|---|---|
| 2023-03-24 - 2023-03-24 | HOLD | 0 |
| 2023-03-20 - 2023-03-24 | SELL | -1.08 |
| 2023-03-16 - 2023-03-20 | HOLD | -3.85 |
| 2023-03-06 - 2023-03-16 | SELL | 6.24 |
| 2023-03-03 - 2023-03-06 | HOLD | 0.87 |
Stock Score Effectiveness
Bollinger Stock Signal Effectiveness
Macd Signal Effectiveness
Mv7 Signal Effectiveness
Score signal
Bollinger Signal Statistics
MV signal statistics
MACD Signal Statistics
About Galapagos NV
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan... GLPG Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
